136 related articles for article (PubMed ID: 35116932)
1. The high expression of lncRNA TUG1 correlates with progressive tumor condition and less satisfying survival profiles in prostate cancer patients.
Yu J; Wang Y; Peng S
Transl Cancer Res; 2019 Sep; 8(5):1817-1825. PubMed ID: 35116932
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.
Li TH; Zhang JJ; Liu SX; Chen Y
Medicine (Baltimore); 2018 May; 97(19):e0575. PubMed ID: 29742691
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
4. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia.
Qin J; Bao H; Li H
Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells.
Li T; Chen Y; Zhang J; Liu S
Medicine (Baltimore); 2018 Sep; 97(36):e12131. PubMed ID: 30200102
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA taurine-upregulated gene 1 promotes cells proliferation, migration and invasion while represses apoptosis, and upregulates AURKA expression in hepatocellular carcinoma.
Kang P; Jiang G; Meng Q; Liu W; Wu X
Int J Clin Exp Pathol; 2018; 11(7):3199-3207. PubMed ID: 31949695
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens.
Luo W; Yu H; Zou X; Ni X; Wei J
Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595
[TBL] [Abstract][Full Text] [Related]
8. Correlation analysis of long non-coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph
Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W
J Clin Lab Anal; 2021 Aug; 35(8):e23583. PubMed ID: 34251066
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA TUG1 promotes progression via upregulating DGCR8 in prostate cancer.
Yang XL; Wei C; Zhang YB; Guo HQ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2391-2398. PubMed ID: 30964164
[TBL] [Abstract][Full Text] [Related]
10. lncRNA RP5-916L7.2 correlates with advanced tumor stage, and promotes cells proliferation while inhibits cells apoptosis through targeting miR-328 and miR-939 in tongue squamous cell carcinoma.
Chen Y; Guo Y; Yan W
Clin Biochem; 2019 May; 67():24-32. PubMed ID: 30825424
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
Yan J; Wang R; Wu Z
J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 correlates with higher T stage and worse overall survival, and promotes cell proliferation while reduces cell apoptosis in breast cancer.
Sun L; Chu H; Li H; Liu Y
Transl Cancer Res; 2019 Apr; 8(2):603-613. PubMed ID: 35116793
[TBL] [Abstract][Full Text] [Related]
13. The Long Noncoding RNA TUG1 Promotes Laryngeal Cancer Proliferation and Migration.
Zhang Z; Wang X; Cao S; Han X; Wang Z; Zhao X; Liu X; Li G; Pan X; Lei D
Cell Physiol Biochem; 2018; 49(6):2511-2520. PubMed ID: 30261503
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498.
Jin G; Yang Y; Tuo G; Wang W; Zhu Z
Neoplasma; 2020 Jul; 67(4):751-761. PubMed ID: 32305055
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of long non-coding RNA TUG1 expression in various cancers: a meta-analysis.
Zhou Y; Lu Y; Li R; Yan N; Li X; Dai T
Oncotarget; 2017 Nov; 8(59):100499-100507. PubMed ID: 29245996
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
Jiang H; Hu X; Zhang H; Li W
Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
[TBL] [Abstract][Full Text] [Related]
18. LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells.
Zhao XB; Ren GS
J Breast Cancer; 2016 Dec; 19(4):349-357. PubMed ID: 28053623
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
[TBL] [Abstract][Full Text] [Related]
20. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
Luo L; Gao Y; Sun X
Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
